Summary
M2 EQUITYBITES-August 30, 2011-Valeant Pharmaceuticals reports rise of USD300m under securities repurchase programme
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Repurchase Programme
The board of directors of Valeant Pharmaceut...
See the full content of this document
Sponsored links
